Table 4. Multivariable logistic regression models evaluating the association between NAFLD Fibrosis Score risk categories and dichotomous cardiometabolic risk factors.

	Low risk advanced fibrosis	Indeterminate risk advanced fibrosis		High risk advanced fibrosis
	OR (95%CI)	OR (95%CI)	P-value	OR (95%CI)	P-value
Hypertension (yes vs no)
MV*	Reference	1.06 (0.71,1.59)	0.77	3.06 (1.33,7.04)	0.009
MV + BMI	Reference	0.87 (0.56,1.36)	0.55	2.05 (0.83,5.07)	0.12
MV + VAT	Reference	0.90 (0.59,1.37)	0.62	2.19 (0.93,5.18)	0.07
Low HDL cholesterol (yes vs no)
MV*	Reference	1.27 (0.84,1.93)	0.26	1.45 (0.72,2.89)	0.30
MV + BMI	Reference	1.23 (0.78,1.93)	0.37	1.35 (0.62,2.94)	0.45
MV + VAT	Reference	1.14 (0.74,1.75)	0.55	1.15 (0.55,2.38)	0.71
High Triglycerides (yes vs no)
MV*	Reference	1.46 (0.98,2.18)	0.06	2.03 (0.99,4.17)	0.05
MV + BMI	Reference	1.22 (0.79,1.89)	0.36	1.41 (0.64,3.12)	0.39
MV + VAT	Reference	1.25 (0.82,1.88)	0.30	1.46 (0.69,3.08)	0.32

NAFLD, Non-alcoholic fatty liver disease; OR, odds ratio; HDL, high density lipoprotein; BMI, body mass index; VAT, visceral adipose tissue.

*Multivariate model (MV): Covariate adjustment included age, sex, smoking status (current vs no), and drinks per day.